The German Paul Ehrlich Institute, which recommended that the German authorities suspend the use of the AstraZeneca coronavirus vaccine, explained that experts have identified new cases of “a special type of cerebral vein thrombosis.” The head of the institution, Klaus Chichutek, told about this in an interview with the ZDF channel.
According to the director of the institute, new cases of thrombosis have been registered since Friday and it is possible that this is due to vaccinations. The German Ministry of Health decided to suspend the use of the vaccine on Monday, March 15, until the possible connection between the administration of the drug and the formation of blood clots is fully understood.
Chichutek explained that even if cases of thrombosis are very rare, it is necessary to completely exclude the possibility that this is due to the vaccine.
European countries have begun to suspend the use of the AstraZeneca vaccine after reports of side effects, including deaths. In total, more than 15 European countries have completely or partially abandoned the drug, in particular France, Italy, Austria, Estonia, Spain. In addition to Europe, the use of the vaccine has been suspended in some countries in Asia and Africa.
Netherlands suspends use of AstraZeneca vaccine
RBC Other videos SHARE Tweet SHARE SHARE MAIL What else to see
Actions in memory of Boris Nemtsov were held in Russia
In Germany, two people were convicted of violating the EU embargo against Russia
Mishustin expects completion of the bulk of mass vaccinations by autumn
To live with wolves
In the Perm Territory, the suspect confessed in the criminal case of the murder of his family
Click to Expand Repeat Video
Events in memory of Boris Nemtsov took place in Russia US Ambassador to Russia John Sullivan visited the site of Boris Nemtsov's murder View on euronews
In Germany, two people were convicted for violating the EU embargo against Russia In Germany, two people were convicted for violating the EU embargo against Russia
Mishustin expects the completion of the bulk of the mass vaccination by the fall The bulk of the mass vaccination against coronavirus in Russia should be completed by the fall of 2021.
On Tuesday, a World Health Organization (WHO) advisory committee will discuss the safety of the AstraZeneca vaccine.
The company itself insists on the safety of its development and points out that there is no evidence of an increased risk of blood clots in those vaccinated. As of March 14, there have been 15 cases of deep vein thrombosis and 22 cases of pulmonary embolism in those vaccinated with the drug in the EU and the UK, the company said. “This is much less than you would expect in the general population,” AstraZeneca said.